Department of Health and Human Services
U.S. Food and
Drug Administration
Congressional Justification
FY 2004 Annual Performance Plan
FY 2003 Revised Final Performance Plan
FY 2002 Annual Performance Report
Part 2: Performance Plan and Report
Introduction
Part 2: Performance Plan and Report presents new FY 2004 and updated FY 2003 performance goals, along with the final FY 2002 performance goals and an update on performance for some FY 2001 goals for each of FDA's programs.
In this section of the Plan, readers will be able to obtain greater detail to support their understanding of the key Performance goals described in Part One.
Each program section includes the following information:
- Total program funding
- A broad description of program activities
- Strategic goals
- Approaches for achieving goals
- A performance goal summary table; and
- A goal-by-goal explanation including some updated FY 2001 results.
The following sections will be covered:
- Agency Wide - Ensures the Agency is streamlined for more cost-effective operations, establishes a strong emergency response capability in the event of terrorist attacks, and establishes global product safety and security.
- Foods - Promotes and protects the public health and economic interest by ensuring that the food supply is safe, nutritious, wholesome, and honestly labeled. The program also ensures that cosmetics are safe and properly labeled.
- Human Drugs - Ensures that all drug products used for the prevention, diagnosis, and treatment of disease are safe and effective; and that information on proper use is available to all users.
- Biologics - Ensures the safety, potency, and effectiveness of biological products for the prevention, diagnosis, and treatment of disease. This includes blood and blood products, blood test kits, vaccines, therapeutic agents, and other biological products.
- Animal Drugs and Feeds - Ensures that only safe and effective animal drugs, devices, feeds, and food additives are marketed; and that foods from animals that are administered drugs are safe for human consumption.
- Medical Devices and Radiological Health - Ensures that medical devices are safe, effective, and properly labeled and that the public is not exposed to unnecessary radiation from medical, industrial, and consumer products.
- National Center for Toxicological Research - Conducts scientific research to develop methods for regulatory applications.
Previous Page | Table Contents | Agency Wide Performance Report
